Stay updated on Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.3%
    Check dated 2024-09-04T05:29:28.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The website has been updated from version v2.10.0 to v2.10.2 on 2024-08-13, indicating new features or improvements.
    Difference
    0.7%
    Check dated 2024-08-13T23:55:34.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    New content was added on August 6, 2024, following the deletion of previous content on July 30, 2024.
    Difference
    0.7%
    Check dated 2024-08-06T22:44:04.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    New content was added on July 30, 2024, following the deletion of previous content on July 24, 2024.
    Difference
    0.3%
    Check dated 2024-07-30T22:42:23.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    New content was added on July 24, 2024, following the deletion of previous content on July 16, 2024.
    Difference
    0.3%
    Check dated 2024-07-24T16:26:01.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.
    Difference
    6%
    Check dated 2024-07-23T14:59:23.000Z thumbnail image

Stay in the know with updates to Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.